Legislative Activity

This resolution expresses the sense of Congress that extreme weather poses unique and severe threats to the health and well-being of children. It urges that solutions to address these escalating dangers must be rapidly and equitably developed and deployed with children's specific vulnerabilities in mind. The bill calls for prioritizing the physical and mental health needs of children in all future climate adaptation and air quality planning efforts.

This resolution declares a health and safety emergency disproportionately affecting children due to prior administration directives that promoted fossil fuels and suppressed climate science. Congress asserts that these actions harm children's fundamental rights to life and a stable environment by worsening climate change impacts. The bill demands the current administration cease policies that increase greenhouse gases and restore access to suppressed climate research. Ultimately, it calls for aligning all energy and climate laws with the duty to protect the rights and future of young people.

The Housing Is a Human Right Act of 2025 aims to combat homelessness and housing instability through comprehensive federal action. It establishes new funding streams and infrastructure investments to build affordable housing and provide direct support services while shifting local responses away from criminalizing poverty. Furthermore, the Act introduces new taxes on high-value real estate transactions to fund these initiatives and mandates stronger civil rights protections across federal housing and assistance programs.

The Student Loan Bankruptcy Improvement Act of 2025 aims to reform the bankruptcy process for student loan borrowers. This bill seeks to lower the current, overly difficult standard required to discharge student loan debt in bankruptcy proceedings. By making these changes, Congress intends to provide struggling borrowers with a genuine opportunity for a financial fresh start.

The Cosmetic Supply Chain Transparency Act of 2025 enhances cosmetic regulation by requiring detailed ingredient and supply chain information sharing between brand owners and suppliers. This law mandates the FDA to create a public list of harmful, nonfunctional chemical traces that suppliers must eventually test for and certify. Importantly, this federal legislation preserves the right of states to enact stricter ingredient or transparency rules than those established here.

The Asunción Valdivia Heat Illness, Injury, and Fatality Prevention Act of 2025 mandates that employers protect workers from dangerous heat stress by establishing comprehensive safety standards. This Act requires the Secretary of Labor to create evidence-based rules covering engineering controls, administrative procedures, required training, and paid rest breaks to prevent heat-related illness. Furthermore, the law establishes strict enforcement mechanisms, whistleblower protections, and specific timelines for the implementation of these new federal heat protection standards.

The Toxic-Free Beauty Act of 2025 establishes new federal standards for cosmetic safety by banning the intentional addition of specific harmful chemicals, such as formaldehyde and certain parabens, in products sold in the U.S. It also sets maximum allowable limits for certain contaminants like 1,4 dioxane and lead. Importantly, this federal legislation does not preempt stricter state laws regarding cosmetic ingredients. These new requirements will take effect for products shipped interstate starting January 1, 2027.

The State-Based Universal Health Care Act of 2025 empowers individual states to design and implement their own comprehensive universal health coverage systems. States can apply for a federal waiver to bypass most existing federal health insurance rules, including major parts of the ACA, Medicare, and Medicaid. In exchange for waiving federal funding, the federal government will transfer equivalent funds to the state, provided the state commits to covering at least 95% of its residents within five years and maintains budget neutrality for the federal government.

The Child Care for Working Families Act establishes comprehensive federal programs to ensure access to high-quality, affordable child care and universal preschool for young children. The legislation creates an entitlement program for child care, mandates that provider reimbursement rates cover actual costs and ensure living wages for staff, and establishes free, universal preschool for 3- and 4-year-olds. Additionally, it provides dedicated funding to stabilize childcare providers and extend the operating hours and compensation for Head Start staff.

The Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2025 aims to significantly increase federal research, public education, and provider awareness regarding uterine fibroids. The bill mandates expanded research coordination across federal agencies and authorizes funding to study the condition, which disproportionately affects minority women. It also requires the creation of public awareness campaigns detailing non-hysterectomy treatment options and mandates data collection on Medicaid/CHIP spending for fibroid treatments.

The Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025 aims to improve the detection and treatment of uterine fibroids. It mandates federal research to develop evidence-based early detection strategies and establishes grant programs for states to fund screening, education, and intervention services, prioritizing vulnerable populations. Furthermore, the bill allocates funding for research into pain management related to fibroid surgery and other uterine conditions.

The Uterine Cancer Study Act of 2025 mandates a comprehensive federal study to investigate the potential link between the use of chemical hair straighteners and the risk of developing uterine cancer. This research must specifically examine disparities in cancer rates among women of color. The study will ultimately recommend whether the FDA should require additional safety testing for these hair products.

This bill, titled the Epstein Files Transparency Act, mandates the Attorney General to release nearly all unclassified Department of Justice records related to Jeffrey Epstein within 30 days of enactment. The legislation strictly limits the justifications for withholding or redacting documents, prohibiting secrecy based on political sensitivity or potential embarrassment. The only permissible redactions involve victim privacy, child sexual abuse material, or narrowly defined threats to active investigations or national security classifications. Upon completion, the Attorney General must submit a detailed report to Congress listing all released and withheld materials, including an unredacted list of all named government officials.

This resolution affirms that diversity, equity, inclusion, and accessibility (DEIA) are fundamental American values necessary to combat persistent discrimination across society. It details how systemic barriers in housing, wealth, healthcare, education, and employment negatively impact marginalized groups. Ultimately, the bill encourages all sectors to actively pursue DEIA initiatives as a means to strengthen the economy and ensure equal opportunity for all citizens.

The Congressional Oversight Access Act prohibits federal employees from using physical force or detaining a Member of Congress who is conducting official oversight activities on federally controlled property. This protection applies when the Member identifies themselves and is not posing a clear and immediate physical danger. The Act ensures Congress can monitor federal operations while still respecting necessary security screenings.

The Pharmacy Benefit Manager Reform Act of 2025 aims to increase transparency and accountability across the prescription drug supply chain. It mandates fairer pharmacy network access for Medicare beneficiaries and imposes strict new financial reporting and service fee requirements on Pharmacy Benefit Managers (PBMs) working with Medicare and private health plans. Furthermore, the bill establishes new federal mechanisms to accurately track drug acquisition costs in Medicaid and explicitly bans the practice of "spread pricing" in state Medicaid contracts.

The Clean Shipping Act of 2025 establishes mandatory, phased-in standards to drastically reduce the carbon intensity of marine fuels used by large vessels on voyages involving U.S. ports, aiming for a 100% reduction by 2050. Additionally, the bill requires the EPA to set standards ensuring that ships docked or anchored in U.S. coastal waters achieve zero greenhouse gas and air pollutant emissions by 2035, or the maximum feasible reduction if that goal proves impossible. The legislation also mandates annual public reporting on fuel usage and emissions data for compliance monitoring.

This resolution recognizes that climate change poses a severe and growing threat to public health across the United States, exacerbating issues like poor air quality, extreme heat, and disease spread. It directs federal agencies, particularly the Department of Health and Human Services (HHS), to rapidly deploy climate resilience funding and technical assistance, prioritizing underserved communities. Furthermore, the bill calls for strengthening key public health offices, improving data collection, and ensuring worker safety through new heat standards. Ultimately, it mandates coordinated federal action to prepare the healthcare system and protect vulnerable populations from climate-related health crises.

The Head Start for Our Future Act updates the Higher Education Act of 1965 by replacing the term "literacy training" with "child development and early learning" when describing eligible community services. This change explicitly ensures that Head Start and Early Head Start programs are recognized under this section of the law. The bill aims to better reflect the comprehensive nature of early childhood education services.

The Food Chemical Reassessment Act of 2025 mandates that the FDA systematically review the safety of at least ten existing food ingredients every three years, starting in 2026. This process targets substances like certain food additives, colorings, and GRAS ingredients, prioritizing those with the greatest public health concern. If a reassessment determines a substance is unsafe, the FDA is required to take regulatory action, such as repealing approvals or revoking authorizations. The Act also establishes an advisory committee to guide the FDA on reassessment standards and methods.